The GeneSight test can inform your health care provider about genes that may impact how you metabolize or respond to certain depression medications. The GeneSight test is intended to supplement other information considered by a doctor as part of a comprehensive medical evaluation, and can be ordered by any prescribing clinician.
Your fingerprint is unique. And like how your fingerprint unlocks your phone, the GeneSight test unlocks your genetic “fingerprint”, providing insight which your clinician can use to inform medication treatment and may improve your chances of finally feeling like yourself again.
Your fingerprint is unique. And like how your fingerprint unlocks your phone, the GeneSight test unlocks your genetic “fingerprint”, providing insight which your clinician can use to inform medication treatment and may improve your chances of finally feeling like yourself again.
Location: United States, Ohio, Mason
Employees: 201-500
Phone: 866.757.9204
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Wireframe ... | wireframev... |
| - | Allos Vent... | allosventu... |
Mentions in press and media 4
| Date | Title | Description |
| 16.11.2020 | Many Older Americans Heading Into The Holidays Feeling Depressed | Nearly Two-Thirds Of Seniors Who Feel Depressed Won’t Seek Treatment (NAPSI)—Many older Americans say they feel depressed—yet the majority of them are not planning to get help, according to a new national survey—though it could make a treme... |
| 22.06.2019 | Pioneering genetic-testing company Myriad's biggest up-and-coming product could be at risk after scientists raised major questions | Advertisement Genetic tests like one offered by Myriad Genetics claim to analyze a patient's DNA and point them to the best depression drug for them. Myriad's test is called GeneSight and costs $2,000. It's covered for seniors on the govern... |
| 28.02.2017 | Mayo Clinic startup OneOme pitches user-friendly pharmacogenomics | The OneOme pharmacogenomic test kit Investigational drugs in the U.S. are required to undergo ‘ADME‘ pharmacology testing to characterize Absorption, Distribution, Metabolism and Excretion. The problem is that individuals process drugs diff... |
| - | Mayo Clinic startup OneOme pitches user-friendly pharmacogenomics | The OneOme pharmacogenomic test kit Investigational drugs in the U.S. are required to undergo ‘ADME‘ pharmacology testing to characterize Absorption, Distribution, Metabolism and Excretion. The problem is that individuals process drugs diff... |